Award

Study of Coronary Hyperpermeability as a Novel Mechanism of Lipid-Induced Cardiac Dysfunction

Description: Dyslipidemia, especially deranged metabolism of low-density lipoprotein (LDL) has been shown to be causally related to the development of coronary artery disease (CAD), which is a known risk factor for heart failure. However, whether circulating lipoproteins could exacerbate cardiac function by direct contact with cardiomyocytes is still unknown. In physiological condition, coronary endothelium acts as a blood–heart barrier, which limits macromolecules including lipoproteins to leak out. Under vascular inflammation associated with trauma, ischaemia–reperfusion injury, sepsis, adult respiratory distress syndrome, diabetes, thrombosis and cancer, the junctions between endothelial cells become dysregulated, which increases the permeability of vasculatures. However, the underlying mechanisms are still unclear and the factors involved in hyperpermeability are not identified either. L5, the most negatively charged subfraction of LDL that we isolated through anion-exchange chromatography in the plasma of patients with vascular inflammation-related diseases, such as hypercholesterolemia, diabetes, smoking, and acute myocardial infarction. Our preliminary results have shown that continuously injecting of the most electronegative LDL, L5, into mice could cause both contractile and conductive dysfunction of heart without any coronary artery events. This makes us to hypothesize L5 could exert its adverse cardiac effects by inducing coronary endothelium hyperpermeability and penetrating the endothelial barrier into cardiac tissues. The proposed study comprises 4 aims designed to address this imperative medical issue from clinical, chemical, cell/molecular, and histological aspects. In aim 1, we will investigate whether L5 can penetrate coronary microvascular and cause cardiac dysfunction by inducing endothelial leakiness. Aim 2 is designed to examine L5’s effect on selected mechanisms contributory to endothelium hyperpermeability. We specifically focus on NO-dependent vascular endothelial growth factor (VEGF) and platelet-activating factor (PAF) pathways. In aim 3, we are trying to examine whether L5-caused cardiac dysfunction exacerbates the effect of L5 on endothelium hyperpermeability in a positive feedback manner. Finally, aim4 is designed for extensive identification of the active lipid components of L5 by lipidome technique. The results will help disclose the mystery of a long lasting question that concerns the public health to the highest degree. The derived conclusions will also provide new clues and direction for further research designed for the development of targeted diagnostic and therapeutic methods with unprecedented accuracy. Because of undisputable importance of this matter, there is a true urgency for the proceeding of this project.
Amount: TWD 1,000,000
Funding type: research
Funder scheme: 學術補助
Investigator: 李安生 (lead)
Institutions: Mackay Medical University, 馬偕醫學院醫學系
Subfield: Immunology
Funded outputs count: 3
Funder award ID: MOST103-2314-B715-008
OpenAlex ID: G4035263824
2015 · Kuan-Cheng Chang, An-Sheng Lee, et al. · Journal of Molecular and Cellular Cardiology · 23